These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16916890)

  • 1. Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals.
    Ansari AW; Bhatnagar N; Dittrich-Breiholz O; Kracht M; Schmidt RE; Heiken H
    Int Immunol; 2006 Oct; 18(10):1443-51. PubMed ID: 16916890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings.
    Ansari AW; Schmidt RE; Heiken H
    Clin Immunol; 2007 Oct; 125(1):1-4. PubMed ID: 17707134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
    Shete A; Dhayarkar S; Dhamanage A; Kulkarni S; Ghate M; Sangle S; Medhe U; Verma V; Rajan S; Hattori T; Gangakhedkar R
    AIDS Res Ther; 2020 Jul; 17(1):43. PubMed ID: 32678033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.
    Scagnolari C; Monteleone K; Selvaggi C; Pierangeli A; D'Ettorre G; Mezzaroma I; Turriziani O; Gentile M; Vullo V; Antonelli G
    Immunobiology; 2016 Feb; 221(2):282-90. PubMed ID: 26563749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
    Thames AD; Briones MS; Magpantay LI; Martinez-Maza O; Singer EJ; Hinkin CH; Morgello S; Gelman BB; Moore DJ; Heizerling K; Levine AJ
    AIDS; 2015 Jul; 29(12):1483-91. PubMed ID: 26244388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.
    Giri MS; Nebozyhn M; Raymond A; Gekonge B; Hancock A; Creer S; Nicols C; Yousef M; Foulkes AS; Mounzer K; Shull J; Silvestri G; Kostman J; Collman RG; Showe L; Montaner LJ
    J Immunol; 2009 Apr; 182(7):4459-70. PubMed ID: 19299747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW; Justement JS; Lempicki RA; Yang J; Dennis G; Hallahan CW; Sanford C; Pandya P; Liu S; McLaughlin M; Ehler LA; Moir S; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1908-13. PubMed ID: 12552096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.
    Sabbatucci M; Covino DA; Purificato C; Mallano A; Federico M; Lu J; Rinaldi AO; Pellegrini M; Bona R; Michelini Z; Cara A; Vella S; Gessani S; Andreotti M; Fantuzzi L
    Retrovirology; 2015 Jan; 12():4. PubMed ID: 25608886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.
    Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V
    BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
    Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
    PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects.
    Patro SC; Pal S; Bi Y; Lynn K; Mounzer KC; Kostman JR; Davuluri RV; Montaner LJ
    J Virol; 2015 Jan; 89(1):799-810. PubMed ID: 25355877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.
    Wu JQ; Sassé TR; Saksena MM; Saksena NK
    Virol J; 2013 Dec; 10():361. PubMed ID: 24370116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome Profiling of Human Monocyte-Derived Macrophages Upon CCL2 Neutralization Reveals an Association Between Activation of Innate Immune Pathways and Restriction of HIV-1 Gene Expression.
    Covino DA; Kaczor-Urbanowicz KE; Lu J; Chiantore MV; Fiorucci G; Vescio MF; Catapano L; Purificato C; Galluzzo CM; Amici R; Andreotti M; Gauzzi MC; Pellegrini M; Fantuzzi L
    Front Immunol; 2020; 11():2129. PubMed ID: 33072075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
    Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
    Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
    Covino DA; Sabbatucci M; Fantuzzi L
    Curr Drug Targets; 2016; 17(1):76-110. PubMed ID: 26687605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.
    Sharkey M; Babic DZ; Greenough T; Gulick R; Kuritzkes DR; Stevenson M
    PLoS Pathog; 2011 Feb; 7(2):e1001303. PubMed ID: 21383975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
    Heggelund L; Damås JK; Yndestad A; Holm AM; Mūller F; Lien E; Espevik T; Aukrust P; Frøland SS
    Clin Exp Immunol; 2004 Oct; 138(1):116-21. PubMed ID: 15373913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.
    Egaña-Gorroño L; Escribà T; Boulanger N; Guardo AC; León A; Bargalló ME; Garcia F; Gatell JM; Plana M; Arnedo M;
    PLoS One; 2014; 9(9):e106360. PubMed ID: 25225963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia.
    Raymond AD; Gekonge B; Giri MS; Hancock A; Papasavvas E; Chehimi J; Kossenkov AV; Nicols C; Yousef M; Mounzer K; Shull J; Kostman J; Showe L; Montaner LJ
    J Leukoc Biol; 2010 Sep; 88(3):589-96. PubMed ID: 20551211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.